Enanta Pharmaceuticals | ENTA - EPS Earnings Per Share


Enanta Pharmaceuticals reported $-1.05 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Immunic USD -0.1 0.03 Dec/2025
Incyte USD 1.81 0.01 Mar/2026
Insmed USD -1.54 0.21 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -1.67 1.87 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026